Last price paid | 0.94 | |
Change | +8.05% [ +0.07 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 16.05.2024 17:20 |
Fixing | n.a. |
Settlement date | 06.10.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | -36.15% |
Year to date (YTD) | -45.35% |
1 month | -34.27% |
3 months | -36.05% |
1 year | n.a. |
3 years | n.a. |
Issue price | 1.48 |
Underlying price on issue | 88.36 |
Premium | 0.01% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1281032750 |
Symbol | INOVBZ |
Security | 128103275 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Novartis N, CH0012005267 |
Underlying ISIN | CH0012005267 |
Funding level | 106.281200 |
Stop-loss level | 103.155800 |
Distance to stop-loss level | 11.38% |
Long/Short type | Short |
Subscription ratio | 14.99 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 04.10.2023 |
Premium | 0.54% |
Premium p.a. | n.a. |
Leverage | 6.54 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 13.665500 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Swiss Re | 107.65 |
ZURICH INSURANCE | 469.10 |
ROCHE GS | 234.80 |
LOGITECH INT. | 81.60 |
Swiss Life Hldg | 662.60 |
Name | Price |
---|---|
Holcim | 78.44 |
ABB Ltd | 47.65 |
UBS | 27.42 |
Lonza Group | 527.40 |
NOVARTIS N | 92.62 |